History shows that metal-based drugs and remedies have been known and used since very
ancient times. For example, silver was employed in the treatment of wounds and ulcers …

Ruthenium complexes with bioactive ligands are becoming promising substitutes for
platinum complexes due to their precise action against various cancers. In the present study …

Increasing numbers of DNA structures are being revealed using biophysical, spectroscopic
and genomic methods. The diversity of transition metal complexes is also growing, as the …

Photoimmunotherapy is attractive for cancer treatment due to its spatial controllability and
sustained responses. This work presents a ferrocene‐containing Ir (III) photosensitizer …

This review illustrates the potential development and delivery of the organometallic half
sandwiched Ruthenium II arene complexes using carrier protein human serum albumin …

Five new anionic aqueous dioxidovanadium (V) complexes,[{VO2L1, 2} A (H2O) n] α (1–5),
with the aroylhydrazone ligands pyridine-4-carboxylic acid (3-ethoxy-2-hydroxybenzylidene) …

Two new dimeric Zn (II)([{ZnL 1 (DMSO 2)} 2]· DMSO (1),[{ZnL 2 Cl} 2](2)) and a novel
tetrameric Zn (II) complex ([(Zn 2 L 3) 2 (μ–OAc) 2 (μ 3–O) 2](3)), where H 2 L 1= 4–(p …

Four new oxidovanadium [VVOL1–4 (ema)] complexes (1–4) have been synthesized using
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …

A pyrazole-appended quinoline-based 4, 4-difluoro-4-bora-3a, 4a-diaza-s-indacene (L1,
BODIPY) has been synthesized and used as a ligand for the preparation of iridium (III) …

Two new μ 2-oxido bridged divanadium (V) complexes,[VV 2 O 3 (L 1, 2) 2](1 and 2) have
been synthesized using bi-negative tridentate ONO-donor ligands, H 2 L 1, 2 (H 2 L 1= 4-tert …